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ABSTRACT
Introduction: Joint contractures are relatively
common disorders that can result in significant,
long-term morbidity. Initial treatment is
non-operative and often entails the use of
mechanical modalities such as dynamic and
static splints. Although widely utilized, there is
a paucity of data that support the use of such
measures. The purpose of this systematic review
was to evaluate the safety and efficacy of
dynamic splinting as it is used to treat joint
contracture in lower extremities, and to
determine if duration on total hours of
stretching had an effect on outcomes.
Methods: Reviews of PubMed, Science Direct,
Medline, AMED, and EMBASE websites were
conducted to identify the term ‘contracture
reduction’ in manuscripts published from
January 2002 to January 2012. Publications
selected for inclusion were controlled trials,
cohort studies, or case series studies employing
prolonged, passive stretching for lower
extremity contracture reduction. A total of 354
abstracts were screened and eight studies (487
subjects) met the inclusion criteria. The primary
outcome measure was change in active range of
motion (AROM).
Results: The mean aggregate change in AROM
was 23.58 in the eight studies examined.
Dynamic splinting with prolonged, passive
stretching as home therapy treatment showed
a significant direct, linear correlation between
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the total number of hours in stretching and
restored AROM. No adverse events were
reported.
Discussion: Dynamic splinting is a safe and
efficacious treatment for lower extremity joint
contractures. Joint specific stretching protocols
accomplished greater durations of end-range
stretching which may be considered to be
responsible for connective tissue elongation.
Keywords: Connective tissue; Dynasplint;
Home therapy; Orthopedics; Rehabilitation
INTRODUCTION
Contracture is the molecular shortening of
connective tissue [1–5]. Contracture includes
realignment of the elastin polypeptide ‘‘bridges’’
across the longitudinal collagen trihedral
scaffolds causing what previously was
considered a ‘‘permanent shortening’’.
Contracture occurs following prolonged joint
positioning (immobilization), excessive
arthrofibrosis (common following surgical
procedures), idiopathic, neural hypertonicity,
and due to obstruction [1–23].
Contracture is clinically different from
ankylosis in that contracture is an exclusively
soft tissue anomaly, whereas ankylosis is an
adhesion between arthritic structures.
Treatment for contracture reduction has
included surgical manipulations [6, 7],
sequential, serial casting [8, 9], and passive
stretching [10–23]. There has been a long
debate on splinting modalities of static
splinting versus dynamic splinting with
sequential tension changes in combination
with other protocols [10–37]. Current
literature has shown dynamic splinting with
prolonged passive stretching to be an effective,
safe modality [11–22, 33–36].
A study completed by Usuba et al. [23]
examined the effect of ‘‘low torque, long
duration’’ stretching on contracture. The
contracture was induced with surgical
immobilization of 66 rat knees and extension
was set at 150 of flexion for 40 days. After
remobilization with removal of the hardware,
the mean flexion contracture was -125 (125
from full extension). The increased contracture
could be attributed to excessive arthrofibrosis;
decreased afferent sensitivity has also been a
proposed factor in contracture development [6,
7, 10, 24]. Rats were randomly assigned to one of
six treatment groups: control, surgical
remobilization, stretching with high torque and
short duration, stretching with high torque and
long duration, stretching with low torque and
short duration, and stretching with low torque
and prolonged duration. Twelve treatments of
stretching occurred over a 4-week period and all
measurements were done by one person. All
treatment groups in this study showed a
significant change in maximal extension under
anesthesia. The only statistically significant
difference between treatment protocols was for
the group that used low torque, long duration
repeated stretching [23]. It is hypothesized that
altered reflex sensitivity may also be involved in
explaining why prolonged durations of passive
stretching are successful in contracture
reduction [10].
A comprehensive program including
prolonged passive stretching is recommended
following a TKA [6, 17, 18, 25, 26]. Deficits in
extension have remained following traditional
therapies delivered after total knee arthroplasty
(TKA) [25] but studies employing prolonged
passive stretching have restored knee extension
deficits following the TKA [17, 18]. The low
torque, prolonged duration stretching modality
was used as the standard of care for chronic
extension deficits of the knee in a study of 121
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patients by Freiling and Lobenhoffer [6]. They
combined surgical resolution with dynamic
splinting immediately following the procedure.
The purpose of this systematic review was to
evaluate the safety and efficacy of dynamic
splinting which delivers low torque, prolonged
duration of stretching to treat joint contracture
in the lower extremities (LE), and to determine
if duration on total hours of stretching had an
effect on outcomes.
METHODS
Reviews of PubMed, Science Direct, Medline,
AMED, and EMBASE websites were conducted to
identify the term ‘contracture reduction’ in
manuscripts published from January 2002 to
January 2012. Publications selected for inclusion
were controlled trials, cohort studies, or case
series studies employing prolonged, passive
stretching for LE contracture reduction. A total
of 354 abstracts were screened and eight studies
(487 subjects) met the inclusion criteria. The
primary outcome measure was a change in
maximal active range of motion (AROM).
Data Analysis
Software used in this data analysis was SPSS.
(SPSS Inc., Chicago, IL, USA). Outcome measures
of these studies examined change in AROM as a
common, dependent variable (Table 1) [6, 11,
15–17, 23]. Since the duration (in weeks), LE
(sample size N) and total hours stretching varied
in the clinical trials, it was decided to analyze
using three weighted dependent variables,
namely, (1) duration-weighted AROM = W1
AROM, (2) study size-weighted AROM = W2
AROM, and (3) hours-weighted AROM = W3
AROM where the weights (for cases) were
calculated as W1 = duration/sum of all
durations, W2 = N/sum of all N, and W3 = total
hours stretching/sum of all total hours
stretching as shown in Tables 1, 2, 3, and 4.
The analysis in this article is based on
previously conducted studies and does not
involve any new studies of human or animal
subjects performed by any of the authors.
RESULTS
Of the eight studies included, four assessed the
knee, three involved toes and two evaluated
ankles (Table 1). The studies ranged from 3 to
25 weeks, with the majority studying
prolonged stretching under low tension. Total
hours of stretching ranged from 4 to 1,260 h.
One study, Usuba et al. [23], involved a
preclinical model.
With the three weighted variables, only the W1
AROM and W3 AROM variables were significantly
correlated with r13 = 0.88 and p value of 0.002.
The correlations among the other variables were
insignificant. This suggests that there was an
outlier in each weighted dependent variable.
The median value of (1) was largest, followed by
(2) and (3) in a hierarchical manner. Table 2
attests that the mean of the hours-weighted
AROM was significant, while the means of the
duration-weighted AROM and the size-weighted
AROM were insignificant at 0.05 significance
level.
The hours-weighted AROM was significantly
different from the size-weighted AROM and
duration-weighted AROM at 0.05 level of
significance. Finally, a principal component
analysis revealed that the variables ‘‘tension’’
and ‘‘stretching’’ had closer proximity than
the variable ‘‘joint’’ in the results of these
principle studies. Likewise, another principal
component analysis revealed that the variables
‘‘duration-weighted AROM’’ and ‘‘hours-weighted
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AROM’’ had closer proximity than the ‘‘size-
weighted AROM’’ in the results of these
principal authors.
Efficacy was proven in the trials examined and
a change in AROM in these studies ranged from 7
to 31, excluding the animal study which showed
maximal improvement up to 78 (Table 1). The
mean aggregate change in AROM was 23.5. The
weighted hours in meta-analysis showed
significant difference within the analysis, and
normal distribution. Both human and animal
studies revealed a greater difference and
improvement with prolonged passive stretching
versus shortdurations of stretching.Therewas also
consistency between studies of prolonged passive
stretching in subjects with outcome in change of
AROM (N = 487, DAROM = 23.5, SD = 7.6).
Dynamic splinting for contracture reduction
showed a direct, linear correlation between the
total number of hours in stretching and restored
AROM. Contracture reduction of the LE that
included dynamic splinting in the initial,
non-operative treatment obtained the greatest
hours of prolonged, passive, biomechanically
appropriate, end-range stretching for the
greatest change in AROM.
There were no adverse events reported in the
studies examined.
DISCUSSION
Therapeutic considerations in treatment of
contractures often include safety, efficacy,
availability, cost, and time. No adverse events
were reported and this is attributed to the fact
that dynamic splinting is non-invasive, with
daily application by the patient or family
caregiver [6, 11–22, 33–35]. With other
therapeutic measures such as serial casting, a
10% rate of adverse events would be expected,














































































































































































































































































































































































































































766 Adv Ther (2013) 30:763–770
123
Efficacy was proven in the clinical trials
examined with improvements in AROM
ranging from 7 to 31. Dynamic splinting has
also shown efficacy in substantially reducing
pain in randomized, controlled trials for plantar
fasciopathy [12] and carpal tunnel syndrome
[34]. Dynamic splinting is prescribed as a
treatment of adhesive capsulitis with physical
therapy because it achieves greater, total
durations of joint specific stretching [35].
Doucet and Mettler [36] reported that dynamic
splinting was also effective in an upper extremity
study on wrist contracture reduction in stroke
patients. Improved passive range of motion was
observed in this 12-week study, but surprisingly
the progress made diminished following
discontinuation from treatment with dynamic
splinting. This finding shows ‘cause and effect’
because the modality improved their ROM and
tone management, but when discontinued, the
stroke patients’ contracture worsened.
The cost of dynamic splinting can be
examined in dollars/hour, in comparison to
manual therapy alone. Many dynamic splints
rent for an average of $400 per month. The cost
of treatment using a Dynasplint (Dynasplint
Table 2 Estimates: dependent variable: compare–with variable
Weighted AROM Mean Std. error 95% Conﬁdence interval
Lower bound Upper bound
Hours-weighted AROM 3.628 0.750 1.792 5.464
Size (N)-weighted AROM -0.514 0.750 -2.350 1.322
Duration-weighted AROM 0.950 0.750 -0.886 2.786
Table 3 Meta-analysis and 95% conﬁdence interval
Dependent variable Compare With Mean difference 95% CI lower Upper
Hours-weighted AROM Low tension High tension 3.27 -0.95 7.5
Long stretch Short stretch 2.92 -8.07 13.02
Joint ankle Joint toe 5.28 -8.91 18.48
Joint ankle Joint knee 5.98 -8.91 20.87
Joint toe Joint knee 0.69 -5.48 6.87
Size-weighted AROM Joint toe Joint knee -0.35 -2.15 1.43
Joint ankle Joint knee -1.1 -3.73 1.52
Joint ankle Joint toe -0.74 -3.58 2.1
Long stretch Short stretch -0.08 -2.96 2.79
Low tension High tension -0.3 -1.47 0.85
Duration-weighted AROM Low tension High tension -0.87 -4.27 2.52
Long stretch Short stretch -0.47 -9.05 8.09
Joint toe Joint knee -0.38 -5.31 4.54
Joint ankle Joint knee 3.04 -7.82 13.92
Joint ankle Joint toe 3.43 -7.4 14.27
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Systems, Inc, Maryland, USA) is approximately
$2/hour of stretching ($400/240 h each month)
and according to national scales, stretching in
manual therapy costs $20 for a 15-min
stretching session equaling $80/hour of
stretching. Dynamic splinting is, therefore,
much more cost-effective than stretching
solely, accomplished at therapeutic clinics.
The time dedicated to stretching with dynamic
splinting is frequently accomplished at night
while sleeping, therefore this has little effect on
work or other therapeutic endeavors. Safety,
efficacy, availability, cost, and time have
positive outcomes with dynamic splinting [6,
11–23, 28, 33–36].
Wu¨lker and Rudert [37] cautioned clinicians
that contracture symptoms might be worsened
if excessive ‘‘forceful attempt to restore a normal
range of motion’’ is made. The protocol of
low-load stretching with sequential tension
changes in the dynamic splinting
accomplishes that protection. Martin et al.
[38] hypothesized that having a modality that
is custom fit to the patient’s foot size increases
compliance in wear and the eventual outcome
in contracture reduction. All of the human
studies examined used custom fitting of the
dynamic splinting devices [11, 13, 15–17, 19].
Regarding study limitations, the publications
selected for review included both animal and
human subjects, and the subjects were not
equal in number. The treatment durations for
different joints in the LE were different because
of different joint specific stretching protocols
(i.e., first metatarsal vs. knee). However, that
difference was included in statistical analysis.
CONCLUSION
The intent of this systematic review was to
evaluate the safety and efficacy of dynamic
splinting which delivers low torque, prolonged
duration stretching to treat joint contracture,
and to determine if duration on total hours of
Table 4 Pairwise comparisons: dependent variable: compare–with variable












Size-weighted AROM 4.142* 1.061 0.008 1.546 6.738
Duration-weighted
AROM
2.678* 1.061 0.045 0.082 5.274
Size-weighted AROM Hours-weighted
AROM
-4.142* 1.061 0.008 -6.738 -1.546
Duration-weighted
AROM





-2.678* 1.061 0.045 -5.274 -0.082
Size-weighted AROM 1.464 1.061 0.217 -1.132 4.060
Based on estimated marginal means
* The mean difference is signiﬁcant at the 0.05 level
a Adjustment for multiple comparisons: least signiﬁcant difference (equivalent to no adjustments)
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stretching had an effect on outcomes. The mean
aggregate change in AROM was 23.5 and a
direct, linear statistical correlation was found
between the total number of hours in stretching
and restored range of motion.
Dynamic splinting is a safe and efficacious
treatment for LE joint contractures. The joint
specific, prolonged, passive stretching protocols
accomplished greater durations of end-range
stretching which may be considered responsible
for the significant connective tissue elongations
seen in the studies examined.
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